What factors influence whether placentas are submitted for pathologic examination? - 10/09/11
Abstract |
OBJECTIVE: Our purpose was to investigate factors associated with submission of placentas for pathologic examination.
STUDY DESIGN: In a population-based study of the etiology of cerebral palsy, data were abstracted for 627 singleton survivors to age 3 years. Children included as cases had moderate-to-severe cerebral palsy; controls were randomly selected infants born in the same counties and years.
RESULTS: Placentas were submitted for pathologic examination for 150 children (24%) of those included in this study. Placentas were more often submitted for children born weighing <1500 gm than for other birth weight groups (p < 0.0001). Placentas from cesarean section deliveries were submitted more often than those from vaginal deliveries (p < 0.0001), elective repeat as often as indicated or emergency cesarean sections. Maternal and neonatal disorders suggested by the College of American Pathologists as indications for placental examination were present in 161 (43%) of controls born weighing ≥2500 gm. These indications were not associated with pathologic submissions.
CONCLUSIONS: Within birth weight groups the main determinant of placental submission for laboratory examination was surgical delivery, whether indicated or elective. Maternal and infant conditions had little influence on the likelihood of submission. (Am J Obstet Gynecol 1997;176:567-71.)
Le texte complet de cet article est disponible en PDF.Keywords : Placental pathology, fetus, neonate
Plan
| From the Neuroepidemiologya and the Biometry and Field Studies Branches,b National Institute of Neurological Disorders and Stroke, and the California Birth Defects Monitoring Program, California Department of Health Services.c |
|
| Supported in part by the National Institute of Neurological Disorders and Stroke, in part by a cooperative agreement with the Center for Environmental Health and Injury Control, Centers for Disease Control and Prevention, in part by funds from the Comprehensive Environmental Response, Compensation, and Liability Act Trust Fund through an interagency agreement with the Agency for Toxic Substances and Disease Registry, Public Health Service. |
|
| Reprint requests: Karin B. Nelson, MD, Federal Building, Room 714, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-9130. |
|
| 6/1/79524 |
Vol 176 - N° 3
P. 567-571 - mars 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
